MRI researchers warn against new EU legislation

European Union legislation designed to limit workers' exposure to electromagnetic radiation will seriously hinder research involving the use of magnetic resonance imaging (MRI), leading investigators warned the British government recently.

Written byStephen Pincock
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

European Union legislation designed to limit workers' exposure to electromagnetic radiation will seriously hinder research involving the use of magnetic resonance imaging (MRI), leading investigators warned the British government recently.

The Physical Agents (Electromagnetic Fields) Directive sets legal limits on electromagnetic radiation exposure across a range of frequencies, including those used in MRI. In a letter to Patricia Hewitt, Britain's secretary of state for health, twelve scientists and clinicians argue those limits "are huge extrapolations from largely hypothetical possible conditions and are an over-cautious interpretation of very limited experimental data."

The result will limit the use of MRI in diagnosis, treatment, and research, which could have potentially disastrous impacts on both the lab and the clinic, they say. "This has implications across all applications of MRI, right through from clinical ones to clinical research and basic research," says Stephen Keevil, a signatory to the letter and head of magnetic resonance ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies